Jamison Norwood, Cathy A Jenkins, Manasa Bhatta, Megan Turner, Aihua Bian, Jeffrey Nelson, Imani Ransby, Dana Hughes, John R Koethe, Timothy R Sterling, Bryan E Shepherd, Jessica L Castilho
Objective: We sought to determine the association of hormonal contraception (HC) and cardiometabolic outcomes among women with human immunodeficiency virus (HIV). Methods: We included women with HIV aged 18-45 years in clinical care in the Southeastern United States between 1998 and 2018. Oral and injectable HC use was captured from medication records. Our outcomes included incident cardiovascular/thrombotic disease (CVD) (atherosclerosis, hypertension, cerebrovascular disease, thrombosis, and heart failure) and incident metabolic disorders (diabetes, dyslipidemia, obesity, and non-alcoholic steatohepatitis)...
March 14, 2024: Journal of Women's Health